Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Bradley S Miller & Kevin C J Yuen. (2022) Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients. Drug Design, Development and Therapy 16, pages 2055-2066.
Read now
Read now
Nanxin Li, Eileen K. Sawyer, Konrad Maruszczyk, Greg Guzauskas, Marta T. Slomka, Tom Burke, Antony P. Martin, Jamie O’Hara, Matt Stevenson & Michael Recht. (2021) Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic model. Journal of Medical Economics 24:1, pages 363-372.
Read now
Read now
Joanna Davis, Songkai Yan, Tadashi Matsushita, Lorenzo Alberio, Paul Bassett & Elena Santagostino. (2019) Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP. Journal of Medical Economics 22:10, pages 1014-1021.
Read now
Read now
Eric P. Velazquez, Bradley S. Miller & Kevin C.J. Yuen. Somatrogon injection for the treatment of pediatric growth hormone deficiency with comparison to other LAGH products. Expert Review of Endocrinology & Metabolism 0:0.
Read now
Read now
Articles from other publishers (8)
Tine M.H.J. Goedhart, A. Janssen, Ron A.A. Mathôt & Marjon H. Cnossen. (2023) The road to implementation of pharmacokinetic-guided dosing of factor replacement therapy in hemophilia and allied bleeding disorders. Identifying knowledge gaps by mapping barriers and facilitators. Blood Reviews 61, pages 101098.
Crossref
Crossref
Bradley S. Miller. (2022) What do we do now that the long-acting growth hormone is here?. Frontiers in Endocrinology 13.
Crossref
Crossref
Cheri L Deal, Joel Steelman, Elpis Vlachopapadopoulou, Renata Stawerska, Lawrence A Silverman, Moshe Phillip, Ho-Seong Kim, CheolWoo Ko, Oleg Malievskiy, Jose F Cara, Carl L Roland, Carrie Turich Taylor, Srinivas Rao Valluri, Michael P Wajnrajch, Aleksandra Pastrak & Bradley S Miller. (2022) Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study. The Journal of Clinical Endocrinology & Metabolism 107:7, pages e2717-e2728.
Crossref
Crossref
RafalRaad Al-Janabi, AfrahA Salih & MohammedJ Alwan. (2021) Evaluation of efficacy of twice-weekly prophylactic treatment with BeneFIX® (recombinant factor IX) followed by once weekly in children with severe hemophilia B: Six-year data from a local registry. Iraqi Journal of Hematology 10:1, pages 59.
Crossref
Crossref
Kuldeep Rajpoot, Muktika Tekade, Mukesh Chandra Sharma, Nagaraja Sreeharsha, Anita Sharma & Rakesh K. Tekade. 2020. The Future of Pharmaceutical Product Development and Research. The Future of Pharmaceutical Product Development and Research
447
482
.
Thierry Lambert, Gary Benson, Gerry Dolan, Cedric Hermans, Victor Jiménez-Yuste, Rolf Ljung, Massimo Morfini, Silva Zupančić-Šalek & Elena Santagostino. (2018) Practical aspects of extended half-life products for the treatment of haemophilia. Therapeutic Advances in Hematology 9:9, pages 295-308.
Crossref
Crossref
Jean Amiral & Jerard Seghatchian. (2018) Usefulness of chromogenic assays for potency assignment and recovery of plasma-derived FVIII and FIX concentrates or their recombinant long acting therapeutic equivalents with potential application in treated pediatric hemophiliac patients. Transfusion and Apheresis Science 57:3, pages 363-369.
Crossref
Crossref
Jean Amiral & Jerard Seghatchian. (2017) Blood derived products in pediatrics: New laboratory tools for optimizing potency assignment and reducing side effects. Transfusion and Apheresis Science 56:2, pages 107-117.
Crossref
Crossref